Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Anavex Life Sciences Corp. (AVXL) had Return on Equity of -10.36% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-9.83M |
|
-- |
|
-- |
|
$10.84M |
|
$-10.84M |
|
$1.02M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-10.84M |
|
$-10.84M |
|
85.29M |
|
85.29M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$103.81M |
|
-- |
|
-- |
|
$103.81M |
|
$8.95M |
|
-- |
|
-- |
|
$8.95M |
|
$94.87M |
|
$94.87M |
|
$94.87M |
|
86.67M |
|
| Cash Flow Statement Financials | |
$-39.04M |
|
-- |
|
$9.43M |
|
$132.19M |
|
$102.58M |
|
$-29.61M |
|
$11.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-39.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-10.36% |
-10.36% |
|
-9.47% |
|
-10.36% |
|
$1.09 |
|
$-0.46 |
|
$-0.46 |
|